Safety and efficacy of laronidase in Chinese patients with mucopolysaccharidosis type I: a phase IV, single-arm, open-label, multicenter study
Chaochun Zou, Xiaoping Luo, Yan Liang, Yuqing Jiao et al.
Journal
Orphanet Journal of Rare Diseases
Topics
Lysosomal Storage Disorders Research
article
Safety and efficacy of laronidase in Chinese patients with mucopolysaccharidosis type I: a phase IV, single-arm, open-label, multicenter study
Chaochun Zou, Xiaoping Luo, Yan Liang, Yuqing Jiao, Yan-Ling Yang, Xin Liu, Li Liu, Yu Wang
article en
Abstract
No abstract available for this paper.
Publication Tag
Orphanet Journal of Rare DiseasesVol. 20(1)
Institutions
Peking University (CN), Children's Hospital of Zhejiang University (CN), Peking University First Hospital (CN), Sanofi (China) (CN), Boehringer Ingelheim (China) (CN), Tongji Hospital (CN), Huazhong University of Science and Technology (CN), Hubei University (CN), Guangzhou Medical University (CN)
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
Safety and efficacy of laronidase in Chinese patients with mucopolysaccharidosis type I: a phase IV, single-arm, open-label, multicenter study — Chaochun Zou, Xiaoping Luo, et al. · Orphanet Journal of Rare Diseases (2025) | TGRS Research Map | TGRS